Prevent Vasculopathy and Nephropathy in Metabolic Syndro
Prevent Vasculopathy and Nephropathy in Metabolic Syndro
批准号:
7040269
负责人:
MICHAEL S GOLIGORSKY
金额:
$31.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2011-01-31
关键词:
antioxidantsapoptosiscardiovascular disorder chemotherapycardiovascular disorder preventioncell senescencediabetic angiopathydiabetic nephropathydisease /disorder etiologyfree radical scavengersgangliosidesgenetic strainintravital microscopylaboratory mouselaboratory ratlysosomesmetabolic syndromemitochondrianitric oxideoxidative stresspathologic processperoxynitritesvascular endotheliumvascular endothelium permeability
中文摘要
描述(由申请人提供):糖尿病和代谢综合征患者的心血管系统加速动脉粥样硬化和早衰已成为流行病。我们之前对内皮细胞在模拟糖尿病环境的微环境下的研究揭示了细胞衰老的加速发展。我们观察到,在过早衰老的细胞中,硝基酪氨酸修饰蛋白的表达增强,而完整细胞经过过氧亚硝酸盐处理后会导致过早衰老,因此,我们用一种真正的过氧亚硝酸盐清除剂/抗氧化剂ebselen处理内皮细胞。这种治疗与预防和逆转过早衰老有关。这些发现促使我们在代谢综合征- Zucker糖尿病大鼠模型中研究细胞过早衰老的分子机制,埃布selen对内皮细胞过早衰老的影响,并检查这些动物血管病变的发展。我们假设氧化应激/过氧亚硝酸盐诱导的溶酶体功能障碍启动内皮细胞衰老和神经节苷的积累,从衰老到凋亡的分子转换-支持血管病变进展的事件。体外和体内研究采用图像分析和荧光活体显微镜,生化技术检测溶酶体和线粒体蛋白的渗漏以及神经节苷脂的积累,定量分析细胞周期标志物,旨在探讨过早衰老和凋亡的分子和细胞机制。用依布硒治疗的Zucker糖尿病脂肪大鼠将进行体内研究,以研究预防和逆转该综合征大血管和微血管病变(肾病)的可能性。这些研究可能揭示内皮细胞过早衰老的机制,过氧亚硝酸盐在启动衰老中的作用,以及过氧亚硝酸盐清除在改善血管病变中的潜在治疗效果。
英文摘要
DESCRIPTION (provided by applicant): Accelerated atherosclerosis and premature aging of the cardiovascular system in patients with diabetes mellitus and metabolic syndrome have acquired epidemic proportions. Our previous studies of endothelial cells subjected to a microenvironment emulating the diabetic milieu revealed accelerated development of cell senescence. Based on the observations that the expression of nitrotyrosine-modified proteins was enhanced in the prematurely senescent cells and peroxynitrite treatment of intact cells led to premature senescence, we treated endothelial cells with a bona fide peroxynitrite scavenger/antioxidant ebselen. Such a treatment was associated with the prevention and reversal of premature senescence. These findings prompted us to investigate the molecular mechanism(s) of premature cell senescence, effects of ebselen on premature endothelial cell senescence in a model of metabolic syndrome - Zucker diabetic rats, and examine the development of vasculopathy in these animals. We hypothesize that oxidative stress/peroxynitrite-induced lysosomal dysfunction initiates endothelial cell senescence and accumulation of gangliosides, a molecular switch from senescence to apoptosis - events underpinning the progression of vasculopathy. In vitro and in vivo studies employing image analysis and fluorescence intravital microscopy, biochemical techniques to detect leakage of lysosomal and mitochondrial proteins as well as accumulation of gangliosides, and quantitative analysis of the markers of cell cycle are designed to investigate molecular and cellular mechanisms of premature senescence and apoptosis. In vivo studies of the Zucker diabetic fat rat treated with ebselen will be conducted to examine the possibility of preventing and reversing macro- and micro-vasculopathy (nephropathy) in this syndrome. The investigations may shed light on mechanisms of premature senescence of endothelial cells, role of peroxynitrite in initiating it, and potential therapeutic efficacy of peroxynitrite scavenging in amelioration of vasculopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx
-
批准号:10428550
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2019
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Glycocalyx repair in sepsis using liposomal carriers of preassembled glycocalyx
-
批准号:10218261
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2019
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
ENDOTHELIAL DYSFUNCTION, NITRIC OXIDE AND RENAL FAILURE
-
批准号:7990202
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:7921552
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7990210
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8298636
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8496014
-
项目类别:
-
资助金额:$32.71万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:7700338
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
Weibel - Palade Bodies - Sentinels of Acute Ischemia
-
批准号:8079698
-
项目类别:
-
资助金额:$33.89万
-
财政年份:2009
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6342524
-
项目类别:
-
资助金额:$21.35万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7341755
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7765494
-
项目类别:
-
资助金额:$28.47万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7173341
-
项目类别:
-
资助金额:$29.35万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:2716760
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6626968
-
项目类别:
-
资助金额:$21.92万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6688324
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
PREVENTION OF VASCULOPATHY AND NEPHROPATHY IN METABOLIC SYNDROME
-
批准号:7568804
-
项目类别:
-
资助金额:$28.76万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6489713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
VASCULAR PERMEABILITY IN DIABETIC NEPHROPATHY
-
批准号:6138083
-
项目类别:
-
资助金额:$20.79万
-
财政年份:1999
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
NITRIC OXIDE IN DEFENSE OF PERITONEAL CAVITY AGAINST MICROBIAL PATHOGENS--CAPD
-
批准号:6283027
-
项目类别:
-
资助金额:$2.44万
-
财政年份:1998
-
负责人:MICHAEL S GOLIGORSKY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: